VANCOUVER- Cognetivity Neurosciences Ltd. (CSE: CGN) (OTCQB: CGNSF) (FSE: 1UB) , a technology company that has created a unique brain health screening platform for use in medical, commercial and consumer environments, announced important validation results for the use of its CognICA technology in measuring the impact of changes in sleep patterns on brain health…
Read More
About The Author
